INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

ISRGINTUITIVE SURGICAL INC

CIK 0001035267

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 10
Max Insider Score38
Connections14with evidence

ISRG · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
325 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nov 4, 2026
  • ← Insider ofevidence
    Wadors Patricia LSVP Chief Human Resources Offi · Oct 26, 2026
  • ← Insider ofevidence
    Guthart Gary SDirector · Oct 26, 2026
  • ← Insider ofevidence
    Barratt Craig HDirector · Oct 26, 2026
17
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL
$27K
61 sh
Oct 29, 2026
Nov 2, 2026
traded Oct 29, 2026
+4d
SEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$101K
567 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$94K
307 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

17
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$29K
63 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
263 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
543 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$57K
325 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$44K
262 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$91K
312 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$70K
307 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$45K
325 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

4
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$43K
546 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
546 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$137K
567 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
262 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
325 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

34
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$2.38M
5,448 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$59K
543 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$48K
263 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
406 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$100K
406 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$141K
406 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

4
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
307 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

4
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
307 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
312 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
406 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$65K
312 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

4
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
312 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

17
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$28K
61 sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC FORM 4

Evidence

17
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$27K
61 sh
Oct 28, 2026Oct 28, 2026
traded Oct 28, 2026
+0dSEC FORM 4

Evidence

17
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$28K
61 sh
Oct 27, 2026Oct 28, 2026
traded Oct 27, 2026
+1dSEC FORM 4

Evidence

2
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$101K
567 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

37
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$1.83M
4,047 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$44K
262 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
307 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

2
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$100K
406 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$48K
263 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

6
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$137K
567 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
325 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
312 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

6
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$141K
406 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
307 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
406 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

6
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$94K
307 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

2
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$57K
325 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

29
GS
Guthart Gary SDirector
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$9.08M
20.1K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

6
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$70K
307 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$45K
325 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
263 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
406 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

2
BH
Barratt Craig HDirector
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$104K
1,150 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
262 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

38
BH
Barratt Craig HDirector
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$510K
1,150 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

7
BH
Barratt Craig HDirector
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
1,150 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

38
WL
Wadors Patricia LSVP Chief Human Resources Offi
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$478K
1,078 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)LDA Q1 2026 first quarter · Health issues, MED · Aug 26, 2026
  • ← Insider ofevidence
    Reed Monica PDirector · Apr 30, 2026
  • ← Insider ofevidence
    Ladd Amy LDirector · Apr 29, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-02-13 · Feb 13, 2026
  • ← Insider ofevidence
    Jeddi ImanSVP & GM da Vinci Platforms & · Feb 10, 2026
  • ← Insider ofevidence
    Curet MyriamEVP & Chief Medical Officer · Jan 30, 2026
  • ← Insider ofevidence
    Brosius MarkSVP & Chief Mfg and Supply Cha · Dec 15, 2025
  • ← Insider ofevidence
    Charlton Henry LEVP & Chief Commercial and Mkt · Nov 13, 2025
  • ← Insider ofevidence
    Miller Brian EdwardEVP & Chief Digital Officer · Nov 12, 2025
  • ← Insider ofevidence
    Widman FredrikVP Corporate Controller · Nov 6, 2025
  • Lobbying

    $290K reported · de-duplicated
    2026 Q2 $130K in-house2026 Q1 $160K in-house
    • FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)$40K2026 Q2 · posted Aug 26, 2026 · Health issues, MED
    • In-house report$160K2026 Q1 · posted Aug 26, 2026 · Trade, TAR, Health issues
    • FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)$40K2026 Q1 · posted Aug 26, 2026 · Health issues, MED
    • In-house report$130K2026 Q2 · posted Aug 26, 2026 · Trade, TAR, Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.